Center for Scientific Review; Amended Notice of Meeting, 59444 [2022-21265]

Download as PDF 59444 Federal Register / Vol. 87, No. 189 / Friday, September 30, 2022 / Notices provide valuable information on the scope of outreach to new clients and clients who have had a lapse in service, which could be an indication of reengagement in care. This module will support project officer monitoring and HRSA’s understanding of service provision. Finally, the information collected in the EHE Triannual Report will complement the annual information collected through the RWHAP Services Report and other reporting mechanisms and support HRSA in its ability to monitor EHE initiative activities and assess progress toward meeting national goals for ending the HIV epidemic. Likely Respondents: RWHAP part A and part B Recipients and Subrecipients funded by the EHE initiative. Burden Statement: Burden in this context means the time expended by persons to generate, maintain, retain, disclose, or provide the information requested. This includes the time needed to review instructions; to develop, acquire, install, and utilize technology and systems for the purpose of collecting, validating, and verifying information, processing, and maintaining information, and disclosing and providing information; to train personnel and to be able to respond to a collection of information; to search data sources; to complete and review the collection of information; and to transmit or otherwise disclose the information. The total annual burden hours estimated for this ICR are summarized in the table below. TOTAL ESTIMATED ANNUALIZED BURDEN HOURS Number of respondents Form name EHE Triannual Module ......................................................... 47 47 Number of responses per respondent 3 ........................ HRSA specifically requests comments on (1) the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, (2) the accuracy of the estimated burden, (3) ways to enhance the quality, utility, and clarity of the information to be collected, and (4) the use of automated collection techniques or other forms of information technology to minimize the information collection burden. Dated: September 26, 2022. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. Maria G. Button, Director, Executive Secretariat. Center for Scientific Review; Notice of Closed Meetings [FR Doc. 2022–21265 Filed 9–29–22; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health [FR Doc. 2022–21251 Filed 9–29–22; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health jspears on DSK121TN23PROD with NOTICES Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Innate Immunity and Inflammation Study Section, October 13, 2022, 9:00 a.m. to October 14, 2022, 6:00 p.m., National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, ND 20892 which was published in the Federal Register on September 12, 2022, 87 FRN 316099. This Meeting is being amended to change the contact person from Shahrooz Vahedi to Kenneth Izumi, Ph.D., Center for Scientific Review, National Institute of Health, 6701 Rockledge Drive, Bethesda, MD, 301– 496–6980. The meeting is closed to the public. VerDate Sep<11>2014 18:52 Sep 29, 2022 Jkt 256001 Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Healthcare Delivery and Methodologies Integrated Review Group; Community Influences on Health Behavior Study Section. Date: October 25–26, 2022. Time: 10:00 a.m. to 8:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). PO 00000 Frm 00056 Fmt 4703 Total responses Sfmt 4703 141 141 Average burden per response (in hours) 2 ........................ Total burden hours 282 282 Contact Person: Annie Laurie McRee, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 100, Bethesda, MD 20892, (301) 827–7396, mcreeal@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Xenobiotic and Nutrient Disposition and Action Study Section. Date: October 27–28, 2022. Time: 8:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: The Alexandrian, 480 King Street, Alexandria, VA 22314. Contact Person: Stacey Nicole Williams, Ph.D., Scientific Review Officer, Center for Scientific Review, 6701 Rockledge Drive, Bethesda, MD 20892, (301) 867–5309, stacey.williams@nih.gov. Name of Committee: Musculoskeletal, Oral and Skin Sciences Integrated Review Group; Oral, Dental and Craniofacial Sciences Study Section. Date: October 27–28, 2022. Time: 9:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Place Georgetown, 2121 M Street NW, Washington, DC 20037. Contact Person: Yi-Hsin Liu, Ph.D., Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4214, MSC 7814, Bethesda, MD 20892, (301) 435– 1781, liuyh@csr.nih.gov. Name of Committee: Digestive, Kidney and Urological Systems Integrated Review Group; Hepatobiliary Pathophysiology Study Section. Date: October 27–28, 2022. Time: 9:00 a.m. to 6:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Rockledge II, 6701 Rockledge Drive, Bethesda, MD 20892 (Virtual Meeting). E:\FR\FM\30SEN1.SGM 30SEN1

Agencies

[Federal Register Volume 87, Number 189 (Friday, September 30, 2022)]
[Notices]
[Page 59444]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-21265]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


Center for Scientific Review; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the Innate 
Immunity and Inflammation Study Section, October 13, 2022, 9:00 a.m. to 
October 14, 2022, 6:00 p.m., National Institutes of Health, Rockledge 
II, 6701 Rockledge Drive, Bethesda, ND 20892 which was published in the 
Federal Register on September 12, 2022, 87 FRN 316099.
    This Meeting is being amended to change the contact person from 
Shahrooz Vahedi to Kenneth Izumi, Ph.D., Center for Scientific Review, 
National Institute of Health, 6701 Rockledge Drive, Bethesda, MD, 301-
496-6980. The meeting is closed to the public.

    Dated: September 26, 2022.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-21265 Filed 9-29-22; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.